Pentam and Pomalidomide drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Pentam (pentamidine isethionate) and Pomalidomide (pomalidomide). Common drug interactions include pleural effusion among females and acute coronary syndrome among males.
The phase IV clinical study analyzes what interactions people have when they take Pentam and Pomalidomide. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.
What is Pentam?
Pentam has active ingredients of pentamidine isethionate. eHealthMe is studying from 5,686 Pentam users. Check the latest studies of Pentam.
What is Pomalidomide?
Pomalidomide has active ingredients of pomalidomide. eHealthMe is studying from 14,524 Pomalidomide users. Check the latest studies of Pomalidomide.
31 people who take Pentam and Pomalidomide together, and have interactions are studied.

What are the common drug interactions of Pentam and Pomalidomide, by gender? *:
female:
- Pleural effusion (water on the lungs)
- Diarrhoea
- Drug intolerance (drug sensitivity)
- Fatigue (feeling of tiredness)
- Nausea (feeling of having an urge to vomit)
- Rash
- Fluid retention (an abnormal accumulation of fluid in the blood)
- Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
- Death
- Dyspnoea (difficult or laboured respiration)
male:
- Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
- Pneumonia
- Erosive duodenitis (a condition that affects the wall of the small intestine)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Haematemesis (vomiting of blood)
- Hepatic enzyme increased
- Hypoxia (low oxygen in tissues)
- Mucosal inflammation (infection of mucous membrane)
- Nausea (feeling of having an urge to vomit)
- Oesophageal infection
What are the common drug interactions of Pentam and Pomalidomide, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Pneumonia
- Toxic neuropathy (nerve damage caused by toxic (harmful) substances)
50-59:
- Death
- Diarrhoea
- Erosive duodenitis (a condition that affects the wall of the small intestine)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Haematemesis (vomiting of blood)
- Mucosal inflammation (infection of mucous membrane)
- Nausea (feeling of having an urge to vomit)
- Oesophageal infection
- Oesophagitis (inflammation of oesophagus)
- Pneumococcal sepsis (pneumococcal sepsis is a serious medical condition where bacteria, specifically streptococcus pneumoniae)
60+:
- Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
- Pleural effusion (water on the lungs)
- Plasma cell myeloma (cancer that begins in plasma cells)
- Thrombocytopenia (decrease of platelets in blood)
- Dyspnoea (difficult or laboured respiration)
- Gastroenteritis norovirus (inflammation of stomach and intestine caused by norovirus infection)
- Hepatic enzyme increased
- Hypoxia (low oxygen in tissues)
- Parainfluenzae virus infection
- Rash
What are the existing conditions these people have? *
- Multiple Myeloma (cancer of the plasma cells): 30 people, 96.77%
- High Blood Pressure: 14 people, 45.16%
- Nausea (feeling of having an urge to vomit): 11 people, 35.48%
- Pain: 8 people, 25.81%
- Indigestion: 8 people, 25.81%
- Constipation: 8 people, 25.81%
- Osteoporosis (bones weak and more likely to break): 6 people, 19.35%
- Insomnia (sleeplessness): 5 people, 16.13%
- Depression: 4 people, 12.90%
- Back Pain: 4 people, 12.90%
* Approximation only. Some reports may have incomplete information.
Do you take Pentam and Pomalidomide?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Pentam (5,686 reports)
- Pomalidomide (14,524 reports)
Browse all drug interactions of Pentam and Pomalidomide:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Pentam:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Pomalidomide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pentam and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pomalidomide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on pentamidine isethionate and pomalidomide (the active ingredients of Pentam and Pomalidomide, respectively), and Pentam and Pomalidomide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Androgenetic Alopecia and Depressed Level Of Consciousness - now
- Could Nasonex cause Blood Chloride Decreased? - a second ago
- Drug interactions of Busulfex and Alkeran - 9 seconds ago
- Could Nasonex cause Nightmares? - 30 seconds ago
- Could Zometa cause Urinary Incontinence? - 35 seconds ago
- Drug interactions of Ketoconazole and Ginkgo Biloba - 37 seconds ago
- Acute Myeloid Leukaemia Aggravated and Thyroid Cancer - 55 seconds ago
- Drug interactions of Flucytosine and Tenofovir Disoproxil Fumarate - a minute ago
- Could Gleevec cause Drug Intolerance? - a minute ago
- Drug interactions of Demerol and Eliquis - a minute ago